MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202617070371 A) filed by Nisshin Seifun Group Inc. on June 05, 2026, for Immunomodulation Agent.
Inventors include Takahashi, Erika; Node, Junichi; Kikuchi, Yosuke; Matsuo, Shuhei; and Omachi, Atsuko.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: This immunomodulation agent contains yeast deposited to the National Institute of Technology and Evaluation under international deposition number NITE BP-04012. Preferably, the immunomodulation agent is for use in modulation of cytokine production. More preferably, the immunomodulation agent modulates the production of a cytokine in macrophage cells or dendritic cells. Further preferably, the immunomodulation agent modulates immunity via TLR2. The cytokine is preferably at least one selected from IL-1ß, IL-6, IL-8, IL-10, IL-12, and TNF-a.
Disclaimer: Curated by HT Syndication.
